/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE
EDMONTON, June 26 /CNW/ - Ceapro Inc. (CZO - TSX Venture) has revised the
terms of the Brokered Private Placement with Northern Securities Inc.
("Northern") previously announced on May 24, 2007 to increase the President's
List Order amount from $500,000 to up to $635,000.00.
Dr. Mark Redmond, Ceapro President and CEO stated, "There has been great
interest in this offering and we wish to accommodate as many new investors as
possible. Therefore, we are revising the terms of the financing to increase
the President's List. The financing will close Wednesday June 27th 2007."
The increase in the President's List Orders will not increase the size of
the offering. The TSX-Venture Exchange has granted the Corporation conditional
approval with respect to the offering.
About Ceapro Inc.
Ceapro Technology Inc., Ceapro Veterinary Products Inc., Ceapro Active
Ingredients Inc. and Ceapro Bioenergy Inc. are wholly owned subsidiaries of
Ceapro Inc., which is a Canadian growth-stage biotechnology company. Our
primary business activities relate to the development and commercialization of
organic products for medical, cosmetic and animal health industries using
proprietary technology and natural, renewable resources. We will be applying
our technology to become an active participant in the bioenergy sector. We
have also introduced health and wellness services employing our CeaProve(R)
diagnostic technology. Ceapro shares trade on the Canadian TSX Venture
Exchange under the symbol CZO. To learn more about Ceapro, visit
The TSX Venture has neither approved nor disapproved of the information
contained herein -
This release may contain forward-looking statements. Various factors
could cause actual results to differ materially from those projected in
forward-looking statements. Although the Company believes that the
forward-looking statements contained herein are reasonable, it can give no
assurance that the Company's expectations are correct. All forward-looking
statements are expressly qualified in their entirety by this cautionary
For further information:
For further information: Dr. Mark Redmond, President and CEO, Ceapro
Inc., Telephone (Edmonton): (780) 421-4555; Nicole Blanchard, B.Sc., B.Comm.
Managing Partner, Sun International Communications, Telephone (Montreal):